Run or sponsor!
Fill in your inscription today and join the Charcot Team during the 20km off Brussels on May 27, 2018. It will be a perfect day and you will be helping the MS-Research.
12 000 patients are counting on this research and thank you.
The laureates of the Charcot Fund 2018 are known: a choice for concrete results, a focus on progressive MS and, as usual, support for innovative basic research.
As an encouragement for the groundbreaking work provided by our researchers, the Fondation Charcot Stichting will increase its financial support in 2018 from 200,000 euros to 300,000 euros. Discover our Newsletter.
Great progress has been made in 30 years! We can now establish a diagnosis much faster and we can implement increasingly effective early treatment...
It illustrates the complexity and time it takes to complete innovative work, the development of new technical tools, the creation of new therapeutic concepts, feasibility tests using experimental animal models, and, finally the “full scale” trials on people and human diseases. Piet Stinissen quite rightly reminds us that some new treatments of MS use monoclonal antibodies, whose discovery dates back to 1975, and which earned Köhler and Milstein the Nobel Prize in Medicine.
